The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title | Intervention | Sponsor Sort descending | Status |
|---|---|---|---|
| Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program | Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention | Alliance for Clinical Trials in Oncology | Recruiting |
| Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer | Carboplatin, Comprehensive Geriatric Assessment, Pembrolizumab, Pemetrexed, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | dietary education and counseling, prostate cancer foundation booklet | Alliance for Clinical Trials in Oncology | Completed |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer | Best Practice, Internet-Based Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Survey Administration | Alliance for Clinical Trials in Oncology | Completed |
| Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions | Best Practice, Decision Aid iCanDecide - ESE website, Decision Aid iCanDecide - S website, Interview, Media Intervention, Quality-of-Life Assessment, Survey Administration, Therapeutic Conventional Surgery, Training | Alliance for Clinical Trials in Oncology | Recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | Megestrol Acetate, Olanzapine, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Recruiting |
| Acute Pain Caused by Paclitaxel in Patients With Cancer | pain questionnaires | Alliance for Clinical Trials in Oncology | Completed |
| Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment | placebo, testosterone | Alliance for Clinical Trials in Oncology | Completed |
| Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy | DLA (diphenhydramine, lidocaine and antacids) rinse, Placebo, doxepin hydrochloride oral solution | Alliance for Clinical Trials in Oncology | Completed |
| Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection | Physical therapy, educational intervention, quality of life assessment | Alliance for Clinical Trials in Oncology | Completed |
Publications
News and Events
AACR Announces 2024 Distinguished Public Service Award Recipients
Date Posted: February 19, 2024
Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023
Worta McCaskill-Stevens, M.D.: An Appreciation for a Driving Force in Cancer Prevention and Addressing Cancer Disparities
Date Posted: November 17, 2023
Acting Chief of Community Oncology and Prevention Trials Research Group Named
Date Posted: November 1, 2023
NCORP Director Worta McCaskill-Stevens Honored with Career Development Award in Her Name
Date Posted: August 24, 2023